Numoda Capital Innovations
3
15M
3
1
3
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. Numoda Capital Innovations appeared to be a CVC structure as part of the corporation. The main department of described VC is located in the Philadelphia.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Numoda Capital Innovations, startups are often financed by Biomark Capital. The meaningful sponsors for the fund in investment in the same round are RUSNANO, RMI Partners, Domain Associates. In the next rounds fund is usually obtained by RUSNANO, National Institutes of Health, Mirae Asset Venture Investment.
Among the most successful fund investment fields, there are Lifestyle, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Evofem Biosciences, MabVax Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2012. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 3
- Investments by industry
- Health Care (2)
- Pharmaceutical (2)
- Biotechnology (2)
- Medical (2)
- Therapeutics (1) Show 2 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MabVax Therapeutics | 20 Nov 2012 | Biotechnology, Medical, Pharmaceutical | Early Stage Venture | 5M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.